166
Participants
Start Date
January 30, 2020
Primary Completion Date
February 28, 2038
Study Completion Date
February 28, 2041
Superion™ IDS device
The Superion™ IDS is a minimally-invasive spinal implant that treats LSS symptoms by limiting extension at the symptomatic level that compresses the neural elements and is designed for percutaneous surgical placement.
Weill Cornell Medical University, New York
Center for Interventional Pain and Spine, Lancaster
The Spine and Nerve Center of Saint Francis Hospital, Charleston
SC Pain and Spine Specialists, Murrells Inlet
Alliance Spine and Pain Centers, Atlanta
Centurion Spine and Pain, Waycross
The Orthopaedic Institute, Gainesville
Holy Cross Hospital, Fort Lauderdale
Michigan Pain Specialists, Ypsilanti
Ascension Alexian Brothers, Elk Grove Village
Rush University Medical Center, Chicago
University of Kansas Hospital, Kansas City
Neuroscience Research Center, LLC, Overland Park
Precision Spine Care, Tyler
North Idaho Day Surgery, Post Falls
Coastal Research Institute, LLC, Carlsbad
Vitamed Research, Rancho Mirage
IPM Medical Group Inc., Walnut Creek
MarinHealth Spine Institute, Larkspur
Pacific Sports and Spine, LLC, Eugene
Swedish Health Services, Seattle
Northwest Pain Care, Spokane
Brigham and Women's Hospital, Boston
Lead Sponsor
Boston Scientific Corporation
INDUSTRY